X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression
about
IAPs: a central element in the NF-κB activating signaling pathwayRegulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data.Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple OpponentsPGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-κB activation and apoptosis in P19 cells.TTRAP is a novel component of the non-canonical TRAF6-TAK1 TGF-β signaling pathwayTransforming growth factor-β and the hallmarks of cancer.Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cellsInhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.A potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapyTGF-β upregulates miR-181a expression to promote breast cancer metastasis.X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axisLYTAK1, a TAK1 inhibitor, suppresses proliferation and epithelial‑mesenchymal transition in retinal pigment epithelium cellsThe pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.Noncanonical TGF-β signaling during mammary tumorigenesis.Role of TGF-β and the tumor microenvironment during mammary tumorigenesisThe relevance of the TGF-β Paradox to EMT-MET programsUpregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells.Post-translational regulation of TGF-β receptor and Smad signaling.Signaling Receptors for TGF-β Family Members.Review and Literature Mining on Proteostasis Factors and Cancer.Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.Knockdown of survivin results in inhibition of epithelial to mesenchymal transition in retinal pigment epithelial cells by attenuating the TGFβ pathway.miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
P2860
Q26866467-D5310282-DEBF-4371-A6C7-41894938EAD4Q33530433-A19A9BE5-563E-44D2-B1D2-B68DAEED8714Q33636203-554DFD10-C2DC-4124-9B44-68D022B3955DQ33704284-20780E7B-5F7D-48AF-8B9B-54D011465B38Q33752909-00DCE688-E7C8-4A3A-BE84-9253B8AF1B04Q33971047-8C915DA7-BB3E-402B-A873-B95D8673EFEFQ34043345-1E4E359E-5253-4523-BB76-F8B312CC0C48Q34789300-DF211CDA-354E-462F-B98A-4B3A9144B720Q34887552-2A67AAF5-DAC8-41C0-9ED6-8822D04D35B2Q35633302-63EC54C6-86DF-4611-BA1C-7FF18AA75F99Q35980393-B4AD45B4-15A0-42D1-99A2-64BD45E4518CQ36495236-2B4D9E2E-1A76-4B2D-B75D-3B75EA19EC66Q36497263-C8AE51E5-AB4B-4207-9AF0-204587152FC7Q36751784-741ACFDB-376B-41EE-9175-5C59FD28A762Q37012399-98B16FE0-D998-4FD0-AF45-F502F42C1C04Q37032199-CA9D8DA6-DC03-40A0-AB37-2B7ECDD5A3B1Q37040558-4E208541-E4CF-434D-BF43-B2A37F4730B8Q37044600-07AAE667-CF2F-4658-AD31-D74822F6E496Q37044604-7563CF12-0035-4836-8D1A-905BDB334F74Q37118399-331F0B35-ABA5-45AE-AB1C-CC6D9C73D2D4Q37464261-D581C2D6-A9FD-4D21-AE12-A55A98257FF2Q38012228-D4792A68-A649-4519-95AE-D81EB01EAFFDQ38915720-1091A43D-DC38-4729-A173-2E5BCBAD4E9FQ38950514-59DEDC07-E0EE-461A-A969-A616EBE580B2Q47115139-B15E30F5-AF86-4B37-8229-0B7663A06B04Q51735022-17D39BD7-6C30-40ED-8F50-7EF6FFD2A1B5Q58706941-40B5F5F0-2821-41E3-8AB8-EE69C32CCB1E
P2860
X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
X-linked inhibitor of apoptosi ...... ring breast cancer progression
@en
X-linked inhibitor of apoptosi ...... ing breast cancer progression.
@nl
type
label
X-linked inhibitor of apoptosi ...... ring breast cancer progression
@en
X-linked inhibitor of apoptosi ...... ing breast cancer progression.
@nl
prefLabel
X-linked inhibitor of apoptosi ...... ring breast cancer progression
@en
X-linked inhibitor of apoptosi ...... ing breast cancer progression.
@nl
P2093
P2860
P356
P1476
X-linked inhibitor of apoptosi ...... ring breast cancer progression
@en
P2093
Jason R Neil
Maozhen Tian
William P Schiemann
P2860
P304
21209-21217
P356
10.1074/JBC.M109.018374
P407
P577
2009-06-15T00:00:00Z